Steven R John from Long Beach, CA, age 59

Lawyers & Attorneys

Steven John, Berkeley CA - Lawyer

view source

Address:

1917 5Th St, Berkeley, CA 94710
(310)4148146 (Office), (310)4148156 (Fax)

Licenses:

California - Active 1981

Education:

University of California - Berkeley
University of California at Davis School of Law

Specialties:

International Law - 34%
Ethics / Professional Responsibility - 33%
Lawsuits / Disputes - 33%

Steven John - Lawyer

view source

Office:

Penningtons Solicitors LLP

ISLN:

920417490

Steven John - Lawyer

view source

Specialties:

International Law
Ethics / Professional Responsibility
Lawsuits / Disputes
Ethics / Professional Responsibility

ISLN:

915989490

Admitted:

1981

University:

University of California, Davis School of Law King Hall, Davis CA

Medicine Doctors

Steven John

view source

Specialties:

Surgery , Neurological

Work:

Franciscan Medical GroupFranciscan Neurosurgery Associates
1608 S J St FL 5, Tacoma, WA 98405
(253)5725115 (phone), (253)2747929 (fax)

Franciscan Medical GroupFranciscan Neurosurgery Associates
11511 Canterwood Blvd NW STE 205, Gig Harbor, WA 98332
(253)8532980 (phone), (253)2747505 (fax)

Languages:

English

Description:

Mr. John works in Gig Harbor, WA and 1 other location and specializes in Surgery , Neurological. Mr. John is affiliated with Saint Anthony Hospital, Saint Clare Hospital, St Joseph Medical Center and Tacoma General Hospital.

Us Patents

Drug Delivery Devices And Methods
view source
US Patent:

8529492, Sep 10, 2013
Filed:

Dec 20, 2010
Appl. No.:

12/973853
Inventors:

Luke Clauson - Redwood City CA, US
Thomas A. Silvestrini - Alamo CA, US
Tsontcho Ianchulev - San Mateo CA, US
Steven John - Fremont CA, US
Assignee:

Trascend Medical, Inc. - Menlo Park CA
International Classification:

A61M 5/00
A61M 37/00
A61M 31/00
A61F 2/14
A61F 11/00
US Classification:

604 8, 604 9301, 623 41, 606108
Abstract:

This disclosure relates generally to methods and devices for use in treating eye conditions with implantable drug delivery devices. One method includes introducing an implant into the suprachoroidal space, wherein the interior volume of the implant is plugged with a drug-release material comprising at least one active agent that elutes through at least one opening in the implant, wherein the drug-release material degrades from the interior volume of the implant over a period time.

Ocular Implant Applier And Methods Of Use
view source
US Patent:

8535333, Sep 17, 2013
Filed:

Jul 29, 2010
Appl. No.:

12/846201
Inventors:

Steven John - Fremont CA, US
Jose Garcia - Fremont CA, US
Richard S. Lilly - San Jose CA, US
Thomas A. Silvestrini - Alamo CA, US
Assignee:

Transcend Medical, Inc. - Menlo Park CA
International Classification:

A61F 11/00
US Classification:

606108
Abstract:

Described herein is a delivery device and methods for delivering an ocular implant into an eye. The delivery device includes a proximal handle portion; a distal delivery portion coupled to a distal end of the handle portion and configured to releasably hold an ocular implant and includes a sheath positioned axially over a guidewire; and a metering system configured to provide visual guidance regarding depth of advancement of an implant positioned on the guidewire into an anatomic region of the eye. Also disclosed is a device and method for loading an implant onto the delivery device.

Ocular Implant With Shape Change Capabilities
view source
US Patent:

8617139, Dec 31, 2013
Filed:

Jun 25, 2009
Appl. No.:

12/492051
Inventors:

Thomas A. Silvestrini - Alamo CA, US
Steven John - Fremont CA, US
Jose Garcia - Fremont CA, US
Richard S. Lilly - San Jose CA, US
Assignee:

Transcend Medical, Inc. - Menlo Park CA
International Classification:

A61M 1/00
US Classification:

604540, 604 504, 604 8, 604 9, 604 10, 604 19, 604 27, 604 28, 604 48, 604 9301, 604541, 604284, 604285, 604286, 604288, 604289, 604290, 427 21, 427 224, 427 225, 600398, 600399
Abstract:

Disclosed are devices, methods and systems for treatment of eye disease such as glaucoma. Implants are described herein that enhance aqueous flow through the normal outflow system of the eye with minimal to no complications. The implant can be reversibly deformed to a first shape, such as a generally linear shape conducive to insertion. Upon insertion, the implant can deform to a second shape, such as a generally non-linear shape conducive to retention within the eye. The shape also improves fluid flow from the anterior chamber and prevents or reduces clogging.

Digital Imaging System For Eye Procedures
view source
US Patent:

20100134759, Jun 3, 2010
Filed:

Jun 25, 2009
Appl. No.:

12/492085
Inventors:

Thomas A. Silvestrini - Alamo CA, US
Steven John - Fremont CA, US
Jose Garcia - Fremont CA, US
Richard S. Lilly - San Jose CA, US
International Classification:

A61B 3/117
A61B 3/14
US Classification:

351206, 351219
Abstract:

Described herein is a hand-held gonioscopic imaging system that can be used to continuously display, capture and record images of the iridocorneal angle within the eye during implantation procedures. The system can be used, for example, during device implantation procedures for the treatment of glaucoma such that landmark identification continues during implantation. Intuitive real-time images viewed through the imaging systems described herein appear to the user to move in the same horizontal orientation as the instrument is actually being moved. The systems described herein also provide independent illumination sources for the camera and the surgical microscope that also have independent illumination controls.

Gonio Lens System With Stabilization Mechanism
view source
US Patent:

20130103145, Apr 25, 2013
Filed:

Oct 19, 2012
Appl. No.:

13/656326
Inventors:

Steven John - Menlo Park CA, US
Richard S. Lily - Menlo Park CA, US
Luke Clauson - Menlo Park CA, US
Steven Vold - Menlo Park CA, US
Brian Walsh - Menlo Park CA, US
International Classification:

A61B 3/117
A61F 2/16
US Classification:

623 612, 351219, 351246
Abstract:

This disclosure relates generally to methods and devices for use in viewing and positioning an eye with a gonio lens system, such as during ocular exams and ocular surgeries. Some embodiments of the gonio lens system can include a gonio lens for viewing one or more tissues and structures of the eye. In addition, the gonio lens system can include one or more positioning features for controlling movement positioning of the eye.

Ocular Implant Applier And Methods Of Use
view source
US Patent:

20140012279, Jan 9, 2014
Filed:

Sep 12, 2013
Appl. No.:

14/025145
Inventors:

Steven John - Menlo Park CA, US
Jose Garcia - Menlo Park CA, US
Richard S. Lilly - Menlo Park CA, US
Thomas A. Silvestrini - Menlo Park CA, US
Assignee:

Transcend Medical, Inc. - Menlo Park CA
International Classification:

A61F 9/00
US Classification:

606107
Abstract:

Described herein is a delivery device and methods for delivering an ocular implant into an eye. The delivery device includes a proximal handle portion; a distal delivery portion coupled to a distal end of the handle portion and configured to releasably hold an ocular implant and includes a sheath positioned axially over a guidewire; and a metering system configured to provide visual guidance regarding depth of advancement of an implant positioned on the guidewire into an anatomic region of the eye. Also disclosed is a device and method for loading an implant onto the delivery device.

Drug Delivery Devices And Methods
view source
US Patent:

20160022486, Jan 28, 2016
Filed:

Jul 27, 2015
Appl. No.:

14/809827
Inventors:

- Menlo Park CA, US
Thomas A. Silvestrini - Alamo CA, US
Tsontcho Ianchulev - Menlo Park CA, US
Steven John - Menlo Park CA, US
International Classification:

A61F 9/00
A61F 9/007
Abstract:

This disclosure relates generally to methods and devices for use in treating eye conditions with implantable drug delivery devices. One method includes introducing an implant into the suprachoroidal space, wherein the interior volume of the implant is plugged with a drug-release material comprising at least one active agent that elutes through at least one opening in the implant, wherein the drug-release material degrades from the interior volume of the implant over a period time.

Drug Delivery Devices And Methods
view source
US Patent:

20140171885, Jun 19, 2014
Filed:

Aug 23, 2013
Appl. No.:

13/975086
Inventors:

- Menlo Park CA, US
Thomas A. Silvestrini - Alamo CA, US
Tsontcho Ianchulev - Menlo Park CA, US
Steven John - Menlo Park CA, US
Assignee:

Transcend Medical, Inc. - Menlo Park CA
International Classification:

A61F 9/00
US Classification:

604290
Abstract:

This disclosure relates generally to methods and devices for use in treating eye conditions with implantable drug delivery devices. One method includes introducing an implant into the suprachoroidal space, wherein the interior volume of the implant is plugged with a drug-release material comprising at least one active agent that elutes through at least one opening in the implant, wherein the drug-release material degrades from the interior volume of the implant over a period time.

Resumes

Steven John Glendale, CA

view source

Work:

ZAYCON FOODS

Mar 2013 to 2000
Lead Copy Writer; Social Media/Marketing Manager WWW.SUPERBOWL-COMMERCIALS.ORG

Dec 2012 to 2000
Lead Writer TOP5.COM
Los Angeles, CA
Nov 2012 to Jan 2014
Lead Writer THREE A.M
Glendale, CA
Mar 2012 to Mar 2012
WRITER PARADIGM
Beverly Hills, CA
Sep 2007 to Feb 2011 PARADIGM

2010 to 2011
Story Department Manager

Education:

EMERSON COLLEGE
Boston, MA
May 2005
Bachelor of Arts in Communications/Film

Name / Title

Company / Classification

Phones & Addresses

Steven John
Executive

Connectivity Communications Co
Communications Services

3447 N Pulaski Rd, Chicago, IL 60641

Steven John
Executive

Connectivity Communications Co
Communication Services, NEC

3447 N Pulaski Rd, Chicago, IL 60641
(773)5835155

Steven St John
President